Cerene

Cerene

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.cerene.com

Last Round

Growth Equity

Sep 9, 2021

Total Funding Raised

$77.8M

Momentum Score

25 /100

Company Overview

Cerene is a healthcare technology company that develops a handheld cryo-thermic medical device to empower women in managing their health with safe, user-controlled, and cost-effective solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endometrial cryoablationcryotherapy deviceendometrial ablationheavy menstrual bleedingmenorrhagia treatmentin-office procedurewomen's healthFemTechgynecology devicecryoablationsingle-use deviceminimally invasive procedurealternative to hysterectomyFDA-approved deviceB2B medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cerene Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cerene Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquitySep 9, 2021
Series C ExtensionAug 23, 2017
Series CAug 31, 2015
DebtOct 15, 2014
Series BMay 2, 2013

Key People

Founding team and executive leadership

Nelson Whistance

President And CEO

Executive Team

Ric Cote

President And CEO, Board Of Directors

Executive Team

Cerene Investors

Notable investors and investment history

InvestorRounds
Scientific Health Development IISeries B
Scientific Health DevelopmentSeries C, Series C Extension
InnovaHealth PartnersGrowth Equity
InCube VenturesSeries C, Series C Extension, Series B
GPG VenturesGrowth Equity
Boston Scientific CorporationSeries B
Third Point VenturesSeries C Extension, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    Robert Brown appointed as new CFO.

  • Oct 16, 2025

    Paul Russo appointed as the new Vice President of Sales.

Cerene Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cerene Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cerene's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range39
Year Founded2002
Last FundingSep 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.